(Q44521759)

English

Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE.

scientific article published on 27 May 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

John G F Cleland

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Alison P Coletta

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ashraf Yassin

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hussien Hado

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Damien Cullington

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ahmed Tageldien Abdellah

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Andrew L Clark

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

27 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

614-620

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Home use of automated external defibrillators for sudden cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.05.003

21 January 2018

Identifiers

10.1016/J.EJHEART.2008.05.003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44521759&oldid=807895123"